Divalent Metal Transporter 1 Regulates Iron-Mediated ROS and Pancreatic β Cell Fate in Response to Cytokines
Publication: Research - peer-review › Journal article – Annual report year: 2012
External
Standard
Divalent Metal Transporter 1 Regulates Iron-Mediated ROS and Pancreatic β Cell Fate in Response to Cytokines. / Hansen, Jakob Bondo; Tonnesen, Morten Fog; Madsen, Andreas Nygaard; Hagedorn, Peter H.; Friberg, Josefine; Grunnet, Lars Groth; Heller, R. Scott; Nielsen, Anja Østergren; Størling, Joachim; Baeyens, Luc; Anker-Kitai, Leeat; Qvortrup, Klaus; Bouwens, Luc; Efrat, Shimon; Aalund, Mogens; Andrews, Nancy C.; Billestrup, Nils; Karlsen, Allan E.; Holst, Birgitte; Pociot, Flemming; Mandrup-Poulsen, Thomas.
In: Cell Metabolism, Vol. 16, No. 4, 2012, p. 449-461.Publication: Research - peer-review › Journal article – Annual report year: 2012
Harvard
APA
CBE
MLA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Divalent Metal Transporter 1 Regulates Iron-Mediated ROS and Pancreatic β Cell Fate in Response to Cytokines
A1 - Hansen,Jakob Bondo
A1 - Tonnesen,Morten Fog
A1 - Madsen,Andreas Nygaard
A1 - Hagedorn,Peter H.
A1 - Friberg,Josefine
A1 - Grunnet,Lars Groth
A1 - Heller,R. Scott
A1 - Nielsen,Anja Østergren
A1 - Størling,Joachim
A1 - Baeyens,Luc
A1 - Anker-Kitai,Leeat
A1 - Qvortrup,Klaus
A1 - Bouwens,Luc
A1 - Efrat,Shimon
A1 - Aalund,Mogens
A1 - Andrews,Nancy C.
A1 - Billestrup,Nils
A1 - Karlsen,Allan E.
A1 - Holst,Birgitte
A1 - Pociot,Flemming
A1 - Mandrup-Poulsen,Thomas
AU - Hansen,Jakob Bondo
AU - Tonnesen,Morten Fog
AU - Madsen,Andreas Nygaard
AU - Hagedorn,Peter H.
AU - Friberg,Josefine
AU - Grunnet,Lars Groth
AU - Heller,R. Scott
AU - Nielsen,Anja Østergren
AU - Størling,Joachim
AU - Baeyens,Luc
AU - Anker-Kitai,Leeat
AU - Qvortrup,Klaus
AU - Bouwens,Luc
AU - Efrat,Shimon
AU - Aalund,Mogens
AU - Andrews,Nancy C.
AU - Billestrup,Nils
AU - Karlsen,Allan E.
AU - Holst,Birgitte
AU - Pociot,Flemming
AU - Mandrup-Poulsen,Thomas
PB - Cell Press
PY - 2012
Y1 - 2012
N2 - Reactive oxygen species (ROS) contribute to target-cell damage in inflammatory and iron-overload diseases. Little is known about iron transport regulation during inflammatory attack. Through a combination of in vitro and in vivo studies, we show that the proinflammatory cytokine IL-1β induces divalent metal transporter 1 (DMT1) expression correlating with increased β cell iron content and ROS production. Iron chelation and siRNA and genetic knockdown of DMT1 expression reduce cytokine-induced ROS formation and cell death. Glucose-stimulated insulin secretion in the absence of cytokines in Dmt1 knockout islets is defective, highlighting a physiological role of iron and ROS in the regulation of insulin secretion. Dmt1 knockout mice are protected against multiple low-dose streptozotocin and high-fat diet-induced glucose intolerance, models of type 1 and type 2 diabetes, respectively. Thus, β cells become prone to ROS-mediated inflammatory damage via aberrant cellular iron metabolism, a finding with potential general cellular implications.
AB - Reactive oxygen species (ROS) contribute to target-cell damage in inflammatory and iron-overload diseases. Little is known about iron transport regulation during inflammatory attack. Through a combination of in vitro and in vivo studies, we show that the proinflammatory cytokine IL-1β induces divalent metal transporter 1 (DMT1) expression correlating with increased β cell iron content and ROS production. Iron chelation and siRNA and genetic knockdown of DMT1 expression reduce cytokine-induced ROS formation and cell death. Glucose-stimulated insulin secretion in the absence of cytokines in Dmt1 knockout islets is defective, highlighting a physiological role of iron and ROS in the regulation of insulin secretion. Dmt1 knockout mice are protected against multiple low-dose streptozotocin and high-fat diet-induced glucose intolerance, models of type 1 and type 2 diabetes, respectively. Thus, β cells become prone to ROS-mediated inflammatory damage via aberrant cellular iron metabolism, a finding with potential general cellular implications.
U2 - 10.1016/j.cmet.2012.09.001
DO - 10.1016/j.cmet.2012.09.001
JO - Cell Metabolism
JF - Cell Metabolism
SN - 1550-4131
IS - 4
VL - 16
SP - 449
EP - 461
ER -